US Stock MarketDetailed Quotes

CKPT Checkpoint Therapeutics

Watchlist
  • 1.790
  • -0.050-2.72%
Close May 28 16:00 ET
65.96MMarket Cap-685P/E (TTM)

Checkpoint Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
-46.35%103K
-91.89%6K
-35.42%31K
72.22%31K
-32.69%35K
-28.36%192K
362.50%74K
65.52%48K
-88.39%18K
Operating revenue
--0
-46.35%103K
-91.89%6K
-35.42%31K
72.22%31K
-32.69%35K
-28.36%192K
362.50%74K
65.52%48K
-88.39%18K
Cost of revenue
Gross profit
Operating expense
-39.57%10.95M
-10.72%52.25M
-39.14%10.18M
-27.82%7.73M
14.41%16.23M
7.12%18.12M
2.69%58.53M
-43.87%16.72M
-5.26%10.71M
52.30%14.18M
Selling and administrative expenses
6.94%2.45M
-0.17%8.69M
-24.42%1.88M
21.13%2.24M
7.14%2.28M
2.18%2.29M
1.90%8.7M
16.64%2.48M
-4.00%1.85M
0.71%2.13M
-General and administrative expense
6.94%2.45M
-0.17%8.69M
-24.42%1.88M
21.13%2.24M
7.14%2.28M
2.18%2.29M
1.90%8.7M
16.64%2.48M
-4.00%1.85M
0.71%2.13M
Research and development costs
-46.31%8.5M
-12.56%43.57M
-41.70%8.3M
-38.01%5.5M
15.70%13.95M
7.88%15.83M
2.83%49.83M
-48.53%14.24M
-5.52%8.87M
67.45%12.05M
Operating profit
39.46%-10.95M
10.60%-52.15M
38.90%-10.17M
27.79%-7.7M
-14.34%-16.2M
-7.25%-18.08M
-2.84%-58.33M
44.09%-16.64M
5.44%-10.66M
-54.68%-14.16M
Net non-operating interest income expense
-90.70%4K
-47.50%84K
-95.89%3K
-86.54%7K
40.91%31K
230.77%43K
201.89%160K
421.43%73K
300.00%52K
69.23%22K
Non-operating interest income
-90.70%4K
-47.50%84K
-95.89%3K
-86.54%7K
40.91%31K
230.77%43K
201.89%160K
421.43%73K
300.00%52K
69.23%22K
Other net income (expense)
-100.01%-1K
104.88%217K
-8.96M
1.97M
-357K
7.57M
-4.45M
Gain on sale of security
-100.01%-1K
104.88%217K
---8.96M
--1.97M
---357K
--7.57M
---4.45M
----
----
----
Income before tax
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
5.80%-10.61M
-54.66%-14.14M
Income tax
Net income
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
5.80%-10.61M
-54.66%-14.14M
Net income continuous Operations
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
5.80%-10.61M
-54.66%-14.14M
Minority interest income
Net income attributable to the parent company
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
5.80%-10.61M
-54.66%-14.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
5.80%-10.61M
-54.66%-14.14M
Basic earnings per share
62.92%-0.33
55.29%-3.17
52.38%-1.1
75.83%-0.29
35.19%-1.05
55.05%-0.89
4.83%-7.09
40.00%-2.31
14.29%-1.2
-35.00%-1.62
Diluted earnings per share
62.92%-0.33
55.29%-3.17
52.38%-1.1
75.83%-0.29
35.19%-1.05
55.05%-0.89
4.83%-7.09
40.00%-2.31
14.29%-1.2
-35.00%-1.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0-46.35%103K-91.89%6K-35.42%31K72.22%31K-32.69%35K-28.36%192K362.50%74K65.52%48K-88.39%18K
Operating revenue --0-46.35%103K-91.89%6K-35.42%31K72.22%31K-32.69%35K-28.36%192K362.50%74K65.52%48K-88.39%18K
Cost of revenue
Gross profit
Operating expense -39.57%10.95M-10.72%52.25M-39.14%10.18M-27.82%7.73M14.41%16.23M7.12%18.12M2.69%58.53M-43.87%16.72M-5.26%10.71M52.30%14.18M
Selling and administrative expenses 6.94%2.45M-0.17%8.69M-24.42%1.88M21.13%2.24M7.14%2.28M2.18%2.29M1.90%8.7M16.64%2.48M-4.00%1.85M0.71%2.13M
-General and administrative expense 6.94%2.45M-0.17%8.69M-24.42%1.88M21.13%2.24M7.14%2.28M2.18%2.29M1.90%8.7M16.64%2.48M-4.00%1.85M0.71%2.13M
Research and development costs -46.31%8.5M-12.56%43.57M-41.70%8.3M-38.01%5.5M15.70%13.95M7.88%15.83M2.83%49.83M-48.53%14.24M-5.52%8.87M67.45%12.05M
Operating profit 39.46%-10.95M10.60%-52.15M38.90%-10.17M27.79%-7.7M-14.34%-16.2M-7.25%-18.08M-2.84%-58.33M44.09%-16.64M5.44%-10.66M-54.68%-14.16M
Net non-operating interest income expense -90.70%4K-47.50%84K-95.89%3K-86.54%7K40.91%31K230.77%43K201.89%160K421.43%73K300.00%52K69.23%22K
Non-operating interest income -90.70%4K-47.50%84K-95.89%3K-86.54%7K40.91%31K230.77%43K201.89%160K421.43%73K300.00%52K69.23%22K
Other net income (expense) -100.01%-1K104.88%217K-8.96M1.97M-357K7.57M-4.45M
Gain on sale of security -100.01%-1K104.88%217K---8.96M--1.97M---357K--7.57M---4.45M------------
Income before tax -4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M5.80%-10.61M-54.66%-14.14M
Income tax
Net income -4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M5.80%-10.61M-54.66%-14.14M
Net income continuous Operations -4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M5.80%-10.61M-54.66%-14.14M
Minority interest income
Net income attributable to the parent company -4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M5.80%-10.61M-54.66%-14.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M5.80%-10.61M-54.66%-14.14M
Basic earnings per share 62.92%-0.3355.29%-3.1752.38%-1.175.83%-0.2935.19%-1.0555.05%-0.894.83%-7.0940.00%-2.3114.29%-1.2-35.00%-1.62
Diluted earnings per share 62.92%-0.3355.29%-3.1752.38%-1.175.83%-0.2935.19%-1.0555.05%-0.894.83%-7.0940.00%-2.3114.29%-1.2-35.00%-1.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg